PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3062060-3	1988	However, there were differential changes in regional vascular sensitivity of NPY following administration of pentolinium and captopril, indicating that "buffer" mechanisms were an important determinant of responses to NPY.	Pentolinium Tartrate	109-120	neuropeptide Y	Rattus norvegicus	77-80	
2782438-3	1989	Pretreatment of rats with 2.0 mg/kg (iv) of phenoxybenzamine, or 7.5 mg/kg (iv) of pentolinium, resulted in a significant reduction in the peak MAP evoked by microinjection of NPY (2.35 nmol) into the posterior hypothalamic nucleus.	Pentolinium Tartrate	83-94	neuropeptide Y	Rattus norvegicus	176-179	
1887927-4	1991	Pretreatment of animals with 7.5 mg/kg iv of the ganglionic blocker pentolinium resulted in a blockade of the increase in MAP evoked by microinjection of NPY (2.4 nmol) or carbachol (3.3 nmol).	Pentolinium Tartrate	68-79	neuropeptide Y	Rattus norvegicus	154-157	
2459544-0	1988	Effect of ganglion blockade with pentolinium on circulating neuropeptide Y levels in conscious rats.	Pentolinium Tartrate	33-44	neuropeptide Y	Rattus norvegicus	60-74	
2459544-5	1988	Pentolinium treatment resulted in significantly lower plasma neuropeptide Y levels (31.0 +/- 6.7 fmol/ml) compared with those of control animals (78.6 +/- 8.2 fmol/ml).	Pentolinium Tartrate	0-11	neuropeptide Y	Rattus norvegicus	61-75